M Margeli
Overview
Explore the profile of M Margeli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
214
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Navarro-Sabate A, Font R, Espinas J, Sola J, Martinez-Soler F, Gil-Gil M, et al.
Cancers (Basel)
. 2025 Jan;
17(2).
PMID: 39857981
Purpose: The aim of this study was to compare estimates of adherence to oral endocrine therapy (OET) based on real-world data (RWD) and on clinical evaluation in people diagnosed with...
2.
Albanell J, Martinez M, Ramos M, OConnor M, de la Cruz-Merino L, Santaballa A, et al.
Eur J Cancer
. 2021 Dec;
161:26-37.
PMID: 34902765
Background: The potential benefit of adding palbociclib to fulvestrant as first-line treatment in hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative endocrine-sensitive advanced breast cancer (ABC) patients remains...
3.
Martin M, Zielinski C, Ruiz-Borrego M, Carrasco E, Turner N, Ciruelos E, et al.
Ann Oncol
. 2021 Jan;
32(4):488-499.
PMID: 33385521
Background: Palbociclib plus endocrine therapy (ET) is the standard treatment of hormone receptor-positive and human epidermal growth factor receptor 2-negative, metastatic breast cancer (MBC). However, its efficacy has not been...
4.
Barnadas A, Munoz M, Margeli M, Chacon J, Cassinello J, Antolin S, et al.
J Patient Rep Outcomes
. 2019 Dec;
3(1):72.
PMID: 31865481
Background: Bone metastasis (BM) is the most common site of disease in metastatic breast cancer (MBC) patients. BM impacts health-related quality of life (HRQoL). We tested prospectively the psychometric properties...
5.
Buckland G, Travier N, Arribas L, Del Barco S, Pernas S, ZAMORA E, et al.
J Hum Nutr Diet
. 2019 Jan;
32(4):468-479.
PMID: 30663156
Background: The influence of nutrition on breast cancer prognosis is still inconclusive and therefore dietary interventions incorporating dietary biomarkers are needed to confirm compliance with dietary goals and clarify biological...
6.
de la Pena F, Andres R, Garcia-Saenz J, Manso L, Margeli M, Dalmau E, et al.
Clin Transl Oncol
. 2018 Nov;
21(1):18-30.
PMID: 30443868
Breast cancer is the most common cancer in women in our country and it is usually diagnosed in the early and potentially curable stages. Nevertheless, around 20-30% of patients will...
7.
Blancas I, Aguirre E, Morales S, Gonzalvez M, Servitja S, Diaz N, et al.
Clin Transl Oncol
. 2018 Oct;
21(4):459-466.
PMID: 30293232
Purpose: To evaluate the efficacy and safety of oral weekly vinorelbine 60 mg/m for metastatic breast cancer (MBC) in patients previously treated with anthracyclines or taxanes in routine clinical practice....
8.
Serra P, Sanz-Santos J, Castella E, Cirauqui B, Andreo F, Llatjos M, et al.
Cytopathology
. 2017 Nov;
29(1):35-40.
PMID: 29119620
Background: In breast cancer patients, the expression statuses of oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) are crucial in the choice of treatment....
9.
Cirauqui B, Margeli M, Quiroga V, Quer A, Karachaliou N, Chaib I, et al.
Tumour Biol
. 2016 Jul;
37(10):13435-13443.
PMID: 27465548
Platinum-based chemoradiotherapy (CRT) is a preferred standard of care for locally advanced head and neck cancer (HNC). However, survival benefit is small, with substantial toxicity and biomarkers of CRT resistance...
10.
Garcia-Saenz J, Bermejo B, Estevez L, Palomo A, Gonzalez-Farre X, Margeli M, et al.
Clin Transl Oncol
. 2015 Oct;
17(12):939-45.
PMID: 26497356
Breast cancer is a major public health problem. Despite remarkable advances in early diagnosis and treatment, one in three women may have metastases since diagnosis. Better understanding of prognostic and...